Audit Monitoring system for medicines and vaccines - Swissmedic
Audit number: 23639
In Switzerland, no therapeutic product may be distributed without authorisation. Authorisation is granted by Swissmedic, the Swiss Agency for Therapeutic Products. The institute monitors the safety of therapeutic products sold in Switzerland. Swissmedic relies on a monitoring system for medicines and vaccines known as "pharmacovigilance". This consists of collecting reports of adverse reactions (ARs) and incidents likely to have an impact on consumer health, then examining them in order to take any necessary safety measures.
- Details
Seitennavigation
- Previous article:Implementation of key recommendations for the electronic patient record and current status - General Secretariat of the Federal Department of Home Affairs and Federal Office of Public Health
- Next article: Licensing and remuneration processes for medicines - Swissmedic and Federal Office of Public Health
Archive health